RE:RE:RE:Financials early next week? Yes Eoganacht and in my post I stated " per official news release " sure because of the nature of importance of this release it would be very welcomed to see current calendar on patients. The upcoming Q2 release might be financial only to Q2 and patient data to current time-line if so that would be great. Either way this data will definitely give us a clear picture. Thanks for your concern.
Eoganacht wrote
Hi 99942Apophis - I think 30 patients should reach 270 days by the end of August. From the Nov. 29 2021 MD&A:
"As of November 29, 2021, (270 days ago) Study II has enrolled and provided the primary study treatment for 30 patients (including three patients from the Study treated at the Therapeutic Dose) for a total of 33 patients..."
Theralase planned to treat patient 25 in 3Q2021. That patient should reach 450 days some time between Friday Nov. 25 and Saturday Dec, 24. at which point Theralase plans to submit the 450 day data of the first 25 to the FDA. As of the end of August patient 25 should reach 330 days.
99942Apophis wrote: Eoganacht wrote
Last year the financials came out on Monday, Aug. 30
In 2020 they came out on Friday, August 28
So probably next Monday the 29th or Tuesday the 30th...
All eyes will be on results for those 11 pending at 270 days...
To be clear the 270 day update will be on 24 patients per official news release, patient 25 should also clear as #25 probably received treatment shortly after and still make the 270 day mark. 3 more trading days at best could stretch to 4 but who cares I'm cracking the champaign Friday evening.